BlackRock’s Monopar Therapeutics MNPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.34M | Buy |
205,169
+190,705
| +1,318% | +$6.82M | ﹤0.01% | 3511 |
|
|
2025
Q1 | $527K | Buy |
14,464
+6,363
| +79% | +$232K | ﹤0.01% | 4333 |
|
|
2024
Q4 | $178K | Buy |
+8,101
| New | +$178K | ﹤0.01% | 4590 |
|
|
2022
Q3 | – | Sell |
-465
| Closed | -$5K | – | 5777 |
|
|
2022
Q2 | $5K | Sell |
465
-2,278
| -83% | -$24.5K | ﹤0.01% | 5589 |
|
|
2022
Q1 | $35K | Sell |
2,743
-112
| -4% | -$1.43K | ﹤0.01% | 5394 |
|
|
2021
Q4 | $46K | Buy |
2,855
+62
| +2% | +$999 | ﹤0.01% | 5344 |
|
|
2021
Q3 | $68K | Sell |
2,793
-216
| -7% | -$5.26K | ﹤0.01% | 5170 |
|
|
2021
Q2 | $89K | Buy |
3,009
+763
| +34% | +$22.6K | ﹤0.01% | 5011 |
|
|
2021
Q1 | $70K | Buy |
2,246
+1,168
| +108% | +$36.4K | ﹤0.01% | 4815 |
|
|
2020
Q4 | $33K | Buy |
1,078
+537
| +99% | +$16.4K | ﹤0.01% | 4644 |
|
|
2020
Q3 | $14K | Sell |
541
-185
| -25% | -$4.79K | ﹤0.01% | 4661 |
|
|
2020
Q2 | $27K | Buy |
726
+165
| +29% | +$6.14K | ﹤0.01% | 4568 |
|
|
2020
Q1 | $20K | Buy |
+561
| New | +$20K | ﹤0.01% | 4548 |
|